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ABSTRAK 
 
PENGENALAN 
Pseudomonas aeruginosa adalah salah satu penyebab keratitis bakteria yang boleh 
menjadi teruk sehingga menyebabkan kebutaan. Fluoroquinolones dan aminoglycosides 
mempunyai keberkesanan klinikal yang diiktiraf terhadap Pseudomonas 
keratitis. Memandangkan perintang antibiotik semakin meningkat pada masa kini, 
keberkesanan antibiotik ini telah berkurang dengan ketara.  Madu tualang dihasilkan oleh 
lebah rock (Apis dorsata) yang membina sarang di dahan-dahan pokok tualang 
(Kompassia excelsa atau Mengaris). Ia digunakan secara umumnya sebagai produk 
perubatan dan makanan di Malaysia. Madu tualang mempunyai potensi untuk membunuh 
dan menyahaktifkan pelbagai jenis bakteria. Selain itu, ia juga mempunyai ciri-ciri anti-
radang dan antioksidan yang boleh memudahkan proses penyembuhan luka. Ciri-ciri 
madu tualang ini menjelaskan potensinya untuk digunakan sebagai agen terapeutik 
alternatif untuk keadaan perubatan tertentu terutamanya jangkitan luka. 
 
OBJEKTIF 
Tujuan kajian ini adalah untuk menilai respon klinikal dan kesan antibakteria madu 
tualang sebagai agen terapeutik alternative di dalam rawatan Pseudomonas keratitis di 
mata arnab. 
 
KAEDAH KAJIAN 
Kajian kawalan rawak di dalam keratitis bakteria telah dijalankan menggunakan mata 
arnab dari September 2014 sehingga September 2016. 30 stroma kornea arnab telah 
disuntik dengan 1,000 unit ‘colony forming units (CFU)’ Pseudomonas aeruginosa di 
ix 
 
dalam setiap mata. Dua puluh empat jam selepas suntikan, arnab-arnab ini dibahagikan 
secara rambang kepada tiga kumpulan dengan 10 arnab di dalam setiap 
kumpulan. Kumpulan A telah dirawat dengan topikal gentamicin 0.3%, kumpulan B 
dengan topikal madu tualang 30%, dan Kumpulan C dengan gabungan topikal gentamicin 
0.3% dan madu tualang 30%. Topikal antibiotik kemudiannya dititis setiap 2 jam untuk 
24 jam pertama di dalam ketiga-tiga kumpulan. Selepas itu, antibiotik telah dititis setiap 
4 jam selama 6 hari. Pemeriksaan klinikal dan min ‘slit lamp examination (SLE)’ yang 
dibuat ke atas mata-mata arnab ini telah didokumenkan  pada hari ke-1, 2, 3, 5 dan 7 
selepas induksi Pseudomonas aeruginosa. Mata-mata ini telah diperiksa dan direkodkan 
secara klinikal menggunakan sistem pemarkahan ulser untuk menyusupan ke dalam 
kornea, ulser kornea, hypopyon dan penembusan kornea. Pada hari ke-7 selepas induksi 
Pseudomonas aeruginosa, arnab-arnab ini telah dieuthanasia dan kornea telah dituai 
untuk menentukan min CFU di dalam setiap kornea. 
 
Data yang diperolehi dianalisis dengan menggunakan ‘Statistical Package for Social 
Science (SPSS)’ versi 22. ‘Repeated measure ANOVA’ dan ‘multivariate analysis of 
variance’ telah digunakan untuk analisis statistik. Untuk data yang tidak sekata, ujian 
‘Kruskal Wallis’ telah digunakan. Oleh itu nilai-nilai ini dinyatakan dalam median (julat 
antara kuartil). Nilai p <0.05 diambil sebagai tidak ketara secara statistik. 
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KEPUTUSAN 
  
Tiada perbezaan statistik yang ketara dalam min skor SLE (p = 0.209) di antara kumpulan 
gentamicin, madu tualang dan gabungan gentamicin-madu tualang di dalam rawatan 
Pseudomonas keratitis. Tiada juga perbezaan ketara dalam median CFU (p = 0,820) di 
antara ketiga-tiga  kumpulan ni pada hari-7 selepas induksi Pseudomonas aeruginosa.  
 
KESIMPULAN 
Topikal gentamicin, topikal madu tualang dan topikal gabungan gentamicin- madu 
tualang menunjukkan tindak balas klinikal dan kesan anti-mikrob yang sama dalam 
rawatan Pseudomonas keratitis di model haiwan.  Kajian lebih lanjut menggunakan saiz 
sampel yang lebih besar dan tambahan kumpulan kawalan adalah penting untuk 
membuktikan kesan antimikrobial madu tualang di dalam rawatan Pseudomonas keratitis. 
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ABSTRACT  
BACKGROUND 
Pseudomonas aeruginosa is a common cause of microbial keratitis that can be sufficiently 
severe to cause a significant loss in visual acuity. Fluoroquinolones and aminoglycosides 
have a well-recognized clinical effectiveness against Pseudomonas-induced keratitis. As 
resistant pathogens are becoming more potent nowadays, the effectiveness of these 
antibiotics are reduced conspicuously. Tualang honey is produced by the rock bee (Apis 
dorsata), which builds hives high up in the branches of the tualang tree (Kompassia 
excelsa or Mengaris). It is used commonly as medicinal product and food in Malaysia. 
Tualang honey has both bactericidal and bacteriostatic properties against a wide range of 
bacteria. Besides that, it has anti-inflammatory and antioxidant properties which can 
facilitate wound healing. The potency of tualang honey against microorganisms suggest 
its potential to be used as an alternative therapeutic agent for certain medical conditions 
especially wound infection. 
 
OBJECTIVE 
To evaluate the clinical response and antibacterial effect of tualang honey as an alternative 
therapeutic agent in Pseudomonas-induced keratitis in rabbit eyes. 
 
METHOD 
An experimental randomized control trial in bacterial keratitis was performed in rabbit 
eyes between September 2014 and September 2016. A total of 30 rabbits' corneas were 
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injected intrastromally with 1,000 colony forming units (CFU) of Pseudomonas 
aeruginosa in each eye. Twenty-four hours after the injection, the rabbits were 
randomised into three groups consisting of 10  rabbits in each group. Group A was treated 
with topical gentamicin 0.3%, Group B with topical tualang honey 30%, and Group C 
with combination of topical gentamicin 0.3% and  tualang honey 30%. Topical antibiotics 
were then administered every 2 hours  for the first  24 hours in all three groups. 
Subsequently, the medications were administered every 4 hours for 6 days. Clinical 
examination and mean slit lamp examination (SLE) of rabbits’ eyes were documented at 
day 1, 2, 3, 5 and 7 post induction of Pseudomonas aeruginosa. The eyes of each group 
were examined and recorded clinically using ulcer scoring system for corneal infiltrate, 
corneal ulcer, hypopyon and corneal perforation. At day 7 post induction of Pseudomonas 
aeruginosa, rabbits were euthanized and corneas were harvested to determine the mean 
CFU per cornea. 
 
The data collected were analyzed using Statistical Package for Social Science (SPSS) 
software version 22. Repeated measure ANOVA with multivariate analysis of variance 
were used for statistical analysis. For the data that was not normally distributed, Kruskal 
Wallis test was used. Thus the values were expressed as median (interquartile range). The 
p value of < 0.05 is considered statistically significant. 
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RESULT 
There was no statistically significant difference in mean SLE score (p=0.209) between 
gentamicin, tualang honey and combination of topical gentamicin-tualang honey groups 
in Pseudomonas-induced keratitis. There was also no significant difference in the level 
of median CFU (p=0.820) among the three groups on day 7 post induction of 
Pseudomonas aeruginosa. 
 
CONCLUSION  
Topical gentamicin, topical tualang honey and combination of topical gentamicin-tualang 
honey shows similar clinical response and antimicrobial effect in treating Pseudomonas-
induced keratitis in animal models. Further studies with bigger sample size and additional 
of a control group are essential to establish tualang honey’s antimicrobial effect in 
Pseudomonas-induced keratitis. 
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CHAPTER 1:  
INTRODUCTION 
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Bacterial keratitis is a sight-threatening infectious disease of the cornea. Pseudomonas 
aeruginosa is an important opportunistic human pathogen and the most common 
causative organism in cases of contact lens related bacterial keratitis (Bourcier et al., 
2003; Green et al., 2008; Goh et al., 2010). Other risk factor for bacterial keratitis are 
ocular surface diseases, ocular trauma, use of immunosuppressive medications and 
ocular surgery (Bourcier et al., 2003).  Corneal ulceration, stromal abscess formation, 
corneal oedema, and anterior segment inflammation are characteristic of infective 
keratitis. Pseudomonas keratitis can cause rapid progression and corneal perforation 
within 24 to 48 hours due to its virulence factors (Tang et al., 2013). 
 
In cases of severe inflammation, formation of a deep ulcer results in thinning of the 
cornea. The most feared complications of Pseudomonas keratitis are corneal 
perforation and secondary endophthalmitis, which can lead to loss of the eye. 
Morbidity occurs with a severe corneal scar and vascularization, which eventually 
threaten the vision. Furthermore, irregular astigmatism is a major issue in healed 
keratitis patients. 
 
Goh and colleagues in Malaysia reviewed 202 contact-lens related corneal ulcer 
patients between 2007 and 2008. The mean age was 26 years old and 71.3% patients 
were females. The commonest organism cultured was Pseudomonas aeruginosa 
(79.7%).  
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A retrospective analysis of clinical and microbiological characteristics of bacterial 
keratitis survey done in Paris, France by Bouncier and co-workers (2003) revealed that 
the mean patient age was 39 years. 152 patients were female while 139 patients were 
male, giving gender distribution close to 1:1 ratio. Among the predisposing factors, 
contact lens wear was the most common and 30% of isolated bacteria were Gram 
negative, mostly Pseudomonas aeruginosa. Ocular surface diseases were present in 
21% of cases and acute corneal trauma in 15% of cases. Gram negative bacteria were 
associated with severe anterior chamber inﬂammation and greater inﬁltrates. 
 
Topical antibiotics constitute the mainstay of treatment in cases of Pseudomonas 
keratitis, with systemic antibiotics used only in cases of corneal perforation or 
endophthalmitis. The most commonly used therapies to treat Pseudomonas keratitis 
are fluoroquinolones or fortified aminoglycosides (Willcox, 2012). Other 
antimicrobials can be used, depending on the clinical progress and laboratory findings. 
If the corneal ulcer is small, peripheral and no impending perforation is present, 
intensive monotherapy is adequate. Combination therapy is indicated in severe cases. 
Ceftazidime, gentamicin, ciprofloxacin and their combinations are commercially 
prepared antimicrobial agents in Malaysian market.  They are proven safe and effective 
clinically (Jones, 1979; O’Brien, 2003).    
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Bacterial keratitis remains one of the most important potential complications of contact 
lens use and refractive corneal surgery. Keeping this in mind, early diagnosis and 
treatment are key to minimizing any vision-threatening sequela. In addition, close 
follow-up, attention to laboratory data, and changing antimicrobials if no clinical 
improvement is evident are important elements for successful outcome. 
 
Generally Pseudomonas aeruginosa is sensitive to fluoroquinolones and 
aminoglycoside, but there have been multi-resistant Pseudomonas aeruginosa strains 
reported in Australia. The strains were resistant to ciprofloxacin, gentamicin, 
tobramycin, and amikacin but were sensitive to ceftazidime, imipenem, meropenem, 
and timentin (Ku et al., 2010).  A retrospective study of antibiotic resistance in 
microbial keratitis in the United Kingdom by Shalchi and co-workers (2011) revealed 
that resistance to Gram positive fluoroquinolones was higher than previously reported 
in the United Kingdom. The same study reported a higher rate of Gram negative 
bacterial keratitis due to increased usage of contact lenses.  
 
Honey has been widely accepted as food and medicine by all generations, traditions, 
and civilizations, both ancient and modern. It is produced by honey bees. Honey has 
been reported to contain about 600 compounds. These include carbohydrates such as 
fructose (38.5%) and glucose (31.0%), proteins, lipids, mineral, vitamins and 
antioxidants (Bogdanov et al., 2007; Israili, 2014). 
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Tualang honey is produced by the rock bee (Apis dorsata), which builds hives high up 
in the branches of the tualang tree (Kompassia excelsa or Mengaris). In Malaysia, 
these trees can reach up to 250 feet in height and are plentiful in the north-eastern 
region in the state of Kedah (Mohamad et al., 2010; Erejuwa et al., 2011). More than 
100 nests may be found on a tualang tree. Such tree can yield about 450 kg (about 
1000 pounds) of honey. Tualang honey is brown in colour with pH of 3.55-4.00 and 
specific gravity of 1.335 (Ghazali et al., 2009). 
 
Physicians have been using honey for therapeutic purposes for a long time. Honey has 
antimicrobial properties and is used widely for wound dressings. Its antimicrobial 
effect is mainly due to the osmotic effect of the substance’s sugars, its acidity, and the 
peroxidase activity (Terrab et al., 2003; Tan et al., 2009; Ghazali et al., 2009; Nasir et 
al., 2010). Tualang honey has both bactericidal and bacteriostatic properties against a 
wide range of bacteria (Tan et al., 2009; Ghazali et al., 2009). This has been reported 
in a study where superior healing was achieved with honey dressings compared to 
conventional silver and aquacel dressings (Halim et al., 2010). 
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In ophthalmic use, it has been reported to have almost equal efficacy as conventional 
treatment in the treatment of alkaline injuries to the cornea (Bashkaranet et al., 2011). 
A double blinded clinical trial by Salehi et al (2014) showed that topical honey can 
improve vernal keratoconjunctivitis symptom such as redness, limbal papillae, and 
allergic reactions. It can reduce the usage of topical steroid to prevent steroid-related 
complications. 
 
Antimicrobial agents are important in preventing progression of infectious diseases 
worldwide. However, as resistant pathogens are becoming more potent nowadays, the 
effectiveness of these antibiotics is reduced to a great extent. This bacterial resistance 
to the antimicrobial agents brings severe adverse effect to public health (Levy and 
Marshall, 2004). Therefore, as an alternative, antimicrobial strategies include revising 
and re-evaluating the therapeutic use of ancient remedies, such as honey (Basualdo et 
al., 2007; Mandal et al., 2010a; Mandal et al., 2010b) which is known to have 
antimicrobial and wound healing properties (Khoo et al., 2010; Sukur et al., 2011; 
Zainol et al., 2013). 
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2.1 INTRODUCTION 
 
Pseudomonas aeruginosa is one of the most common causes of microbial keratitis that 
cause sight threatening condition (Jeng and McLeod, 2003).  Widespread use of 
contact lenses has greatly increased the incidence of Pseudomonas aeruginosa keratitis 
which can progress rapidly to corneal perforation in less than 24 hours (Dart et al., 
1991; Ostler, 1993; Bourcier et al., 2003; Fong et al., 2004). Therefore, timely 
antimicrobial treatment must be initiated for rapid eradication of this infecting 
organism. 
 
Ceftazidime, gentamicin, ciprofloxacin or their combinations have been the first line 
of treatment in the current practice. They are proven safe and effective clinically. 
(Jones, 1979; O’Brien, 2003).   However, there are recent reports regarding resistance 
to gentamicin and ciprofloxacin in treating microbial keratitis in Australia, Europe and 
North America (Ly et al., 2006; Green et al., 2008; Wilcox, 2011; Lichtinger et al., 
2012).  At present, there is no incidence reported in South East Asian countries.  
 
Honey is a natural sweetener produced by honey bees. It is a concentrated aqueous 
solution of inverted sugar with a complex mixture of fructose (38%), glucose (31%), 
and other sugars. Honey contains more than 180 substances, including amino acids, 
vitamins, minerals and enzymes like oxidase, amylase and catalase (Perez et al., 2002; 
Terrab et al., 2003).  Tualang honey is taken from beehive on tualang tree (Kompassia 
excelsa or Mengaris) which is produced by the rock bee (Apis dorsata). In Malaysia, 
it is commonly found in Kedah rainforest (Mohamad et al., 2010; Erejuwa et al., 2011).  
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Honey has used widely for wound dressing due to its bactericidal and bacteriostatic 
properties against a wide range of bacteria (Tan et al., 2009; Ghazali et al., 2009). It is 
reported in a study where superior healing achieved with honey dressing compared to 
conventional silver and aquacel dressings (Khoo et al., 2010). The antibacterial effect 
of tualang honey was concentration dependent and bactericidal effect was observed at 
concentration of 25% or more for Pseudomonas aeruginosa isolates tested (Tan et al., 
2009). Besides its antimicrobial properties, honey also anti-inflammatory and an 
antioxidant properties which can be used to treat infection (Tan et al., 2009; Zainol et 
al., 2013). Tualang honey also was proven to facilitate wound healing such as moist 
burns and several other types of wounds (Ahmed et al., 2013).  
 
As antibiotic resistance of bacteria in on the rise, the discovery of alternating 
therapeutic agents is essential (Tan et al., 2009). Since Malaysian tualang honey is 
known to have antimicrobial and wound healing properties, it can be used as an 
alternative for therapeutic purpose (Khoo et al., 2010; Sukur et al., 2011; Zainol et al., 
2013). 
 
Our literature review revealed that there is no published report on tualang honey use 
to treat infective condition in the eyes.  Thus, it is our sincere hope that this study will 
be able to provide new knowledge regarding possibly of its role in the treatment of 
ocular infection. 
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2.2 OBJECTIVES 
 
        2.2.1 General Objective 
To evaluate the clinical response and antibacterial effect of tualang honey in 
keratitis induced by Pseudomonas aeruginosa in rabbit eyes. 
 
2.2.2 Specific Objectives 
 
i. To compare mean Slit Lamp Examination (SLE) score of 
Pseudomonas-induced keratitis between topical gentamicin 0.3%, 
topical tualang honey 30% and combination of topical gentamicin 0.3% 
and tualang honey 30% in rabbit eyes on day 1, 2, 3, 5, and 7 post 
induction of Pseudomonas aeruginosa . 
 
ii. To compare mean bacterial colony forming units (CFU) of 
Pseudomonas-induced keratitis between topical gentamicin 0.3%, 
topical tualang honey 30% and combination of topical gentamicin 0.3% 
and tualang honey 30% in rabbit eyes on day 7 post induction of 
Pseudomonas aeruginosa. 
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2.3 RESEARCH HYPOTHESIS 
 
i. There is difference of mean SLE score of Pseudomonas-induced keratitis in 
eyes of rabbits between topical gentamicin 0.3%, topical tualang honey 30% 
and combination of topical gentamicin 0.3% and tualang honey 30% on day 1, 
2, 3, 5, and 7 post induction of Pseudomonas aeruginosa. 
 
ii. There is difference of mean bacterial CFU in Pseudomonas-induced keratitis 
in eyes of rabbits between topical gentamicin 0.3%, topical tualang honey 30% 
and combination of topical gentamicin 0.3% and tualang honey 30% on day 7 
post induction of Pseudomonas aeruginosa. 
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2.4 DEFINITION OF TERMS 
 
i. Tualang honey: 100% pure honey supplied by FAMA, Malaysia and was taken 
from the beehive on tualang tree in Kedah rainforest. 
 
ii. Pseudomonas-induced keratitis: a disease of the cornea that result from direct 
infection of Pseudomonas aeruginosa and complicated with massive 
destruction of the cornea (Wilson, 1970). 
 
iii. SLE score: grades of ulcer scoring system assessed using slit lamp examination 
based on corneal infiltrates, corneal ulcer, hypopyon and corneal perforation 
(Dong et al., 2012). 
 
iv. Bacterial CFU: a quantitative bacterial colony analysis on the diseased corneal 
button (Barequet et al., 2004; McCormick et al., 2008). 
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2.5 METHODOLOGY 
 
2.5.1 Study Design 
 
Randomized control trial in animal study. 
 
2.5.2 Population and Sample 
 
Study population: New Zealand white adult rabbits will be obtained from Animal 
Research and Service Centre, Universiti Sains Malaysia, Health Campus, Kubang 
Kerian, Kelantan, Malaysia. 
 
Place of study: Animal Research and Service Centre, Microbiology Laboratory 
and Pharmacological Laboratory, Universiti Sains Malaysia, Health Campus, 
Kubang Kerian, Kelantan, Malaysia. 
 
Duration of study: 2 years (September 2014 – September 2016). 
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2.5.3 Selection Criteria 
 
i. Inclusion Criteria: 
 Healthy adult rabbits with clear cornea. 
 Successfully induces Pseudomonas aeruginosa keratitis. 
 
ii. Exclusion Criteria: 
 Severe systemic infection with Pseudomonas aeruginosa. 
 
 
2.5.4 Sampling and Sample Size 
 
Sample size was calculated based on the first and second objectives.  Sample size 
for the first and second objective is calculated by using G power and sample size 
calculation version 3.1.9. 
 
i. First Objective: To compare mean SLE score of Pseudomonas-induced 
keratitis between topical gentamicin 0.3%, topical tualang honey 30% and 
combination of topical gentamicin 0.3% and tualang honey 30% in rabbit 
eyes on day 1, 2, 3, 5, and 7 post induction of Pseudomonas aeruginosa. 
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Effect size   = 0.4 
Power   = 80% 
Alpha level  = 5% (0.05) 
Number of group  = 3 
Number of evaluation = 5 
Calculated sample size is 12 rabbits per group 
 
ii. Second Objective: To compare mean bacterial CFU of Pseudomonas- 
induced keratitis between topical gentamicin 0.3%, topical tualang honey 
30% and combination of topical gentamicin 0.3% and tualang honey 30% 
in rabbit eyes on day 7 post induction of Pseudomonas aeruginosa. 
 
Effect size   = 0.4 
Power   =80% 
Alpha Level  = 5% (0.05) 
Number of group  = 3 
Calculated sample size is 22 rabbits per group 
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In view of the largest sample size (Second objective = 22 rabbits) is too big, 
sample size is chosen as 10 rabbits per group as suggested by the Animal 
Research Committee.  
 
Number of rabbits needed for the preliminary study = 3  
Number of rabbits per group in actual study = 10 
Total number of rabbits needed = (10 x 3) + 3 = 33 
 
2.5.5 Randomization Method 
 
New Zealand white adult rabbits (aged 8 – 10 months) weighting between 2.5 and 
3.0 kg will be used in this study.  The rabbits will be randomly divided into 3 groups 
(A, B and C) consisting of 10 rabbits in each group.  
 
a) The Group A will be treated with topical gentamicin 0.3%. 
b) The Group B will be treated with topical tualang honey 30%. 
c) The Group C will be treated with combination of topical gentamicin 0.3% and 
topical tualang honey 30%. 
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2.5.6 Study Material  
 
i. Animals handling  
New Zealand white adult rabbits 
Rabbit cage and bedding 
Elizabeth collar 
 
ii. Drugs and Solution 
Ketamine hydrochloride (100mg/ml) 
Xylazine hydrochloride (20mg/ml) 
Pentobarbitol (60mg/ml) 
Povidone iodine (10mg/ml) 
Propacaine hydrochloride 0.5% eye drop 
Gentamicin 0.3% eye drop 
Tualang honey 30% eye drop 
Fluorescein ophthalmic strip (1mg/strip) 
Pseudomonas aeruginosa (strain 27853) 
Trypticase soy agar plates 
Trypticase soy broth 
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iii. Surgical Instruments  
Needles (22G, 27G and 28G) 
Syringes (1ml, 5 ml) 
Tuberculin syringes  
Caliper 
Paediatric Barraquer wire speculum  
Conjunctival forcep 
Surgical glove 
Surgical drape 
Shaver blade 
Corneal scissors 
Heine HR Binocular loupe with LED light 
 
iv. Laboratory Instruments and Disposables 
Topcon SL-7E biomicroscope 
Weighing scale machine 
Centrifuge tube (2ml, 5ml) 
Beaker (150ml) 
Goggles 
Repeat pipette 
Disposable biohazard bag 
  Gauze 
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2.5.7 Study Procedures 
 
a) Phase 1 (Preliminary Study) 
A preliminary study will be carried out prior to the actual study to establish 
the Pseudomonas-induces keratitis injury in rabbits. Three rabbits will be 
used in the preliminary study. 
  
i. Maintenance of rabbits 
The rabbits will be maintained and handled according to the 
recommendations of the animal ethics guidelines. Animals will be 
housed individually in stainless steel cages under controlled 
temperature, humidity and 12 hour light; dark cycle.  Food and 
water will be provided ad libitum.  The eyes of all rabbits will be 
examined with a microscope before the induction of Pseudomonas 
aeruginosa to make sure that their corners are normal. 
 
ii. Preparation of Pseudomonas aeroginosa colony 
Pseudomonas aeroginosa, strain 27853, will be used in this study.  
It is well documented strain for the testing of treatment response and 
courses well characterized keratitis in rabbits (McCormick et al., 
2008). Single colony of Pseudomonas aeroginosa will be cultured 
in tryptic soy agar (TSA) overnight at 37°C. The overnight culture 
was inoculated into fresh tryptic soy broth (TSB) (1:100) and grown 
at 37°C. To infect rabbit corneas, the bacteria were serially diluted 
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in TSB to 10,000 CFU per ml. Diluted bacteria then plated and 
verified by a quantitative bacterial count on TSA. 
 
iii. Preparation of topical tualang honey 
Tualang honey will be obtained from Federal Agriculture Marketing 
Authority (FAMA), Kedah.  The honey will be stored in the dark at 
room temperature and then will be subjected to sterilization by 
irradiation followed by sterility test prior to treat rabbits’ eyes. 
Tualang honey with 30% concentration of will be freshly prepared 
everyday by mixing 1.5 ml of honey with 3.5 ml of distilled water 
in the morning just before the first instillation. 
 
iv. Induction of Pseudomonas aeruginosa keratitis 
The first rabbit will be anaesthetised with an intramuscular dose of 
ketamine hydrochloride (100mg/ml; 35mg/kg) and xylazine 
hydrochloride (20mg/ml; 2.4mg/kg) approximately 45 minutes 
prior to induction of Pseudomonas aeruginosa keratitis. The 
experiment will be carried out only on the right eye of each rabbit.  
A drop of propacaine hydrochloride 0.5% will be instilled to the 
right eye followed by insertion of barraquer wire speculum.  Corneal 
stromal of anaesthetised rabbits will be injected with 1000 CFU of 
bacteria in 0.1ml of TSB (Thibodeaux et al, 2004; McCormick et al, 
2008; Nejabat et al, 2009). 
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v. Clinical eye examination 
The right eye of the rabbits will be examined to evaluate the clinical 
features with a microscope at day 1, 2, 3, 5, and 7 post induction of 
Pseudomonas aeruginosa.  SLE of pathological changes in rabbit 
eyes will be performed by a single blinded examiner. The scoring 
system for SLE of the cornea will be done as per in Table 1. 
 
Table 1: SLE score  
  
Note: Adapted from Dong et al, 2012 
 
 
vi. Preparation of corneal button 
The rabbit will be euthanized after anaesthetized and administered a 
lethal dose of injection of intravenous pentobabitol (60 mg/kg) on day 
7 post induction of Pseudomonas aeruginosa. The cornea will be 
excised and will be send for microbiological examination. 
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vii.  Calculation of bacterial CFU 
Cornea will be placed into sterile phosphate-buffered saline (0.1M, 
pH 7.2; PBS) and homogenized. Homogenized cornea will be serially 
diluted (1:10) in fresh TBS and plated, in triplicate, on TSA. Plates 
will be incubated at 37°C overnight. The bacterial colonies were 
identified using the colony morphology and Gram staining, then 
counted to determine the mean CFU per cornea. Sterility was 
maintained throughout the procedures to avoid cross-contamination. 
 
b) Phase II (Actual Study) 
Actual study will be conducted with 10 rabbits in each group. 
 
i.    Maintenance of rabbit 
Rabbits will be maintained as per mentioned in 5.7.1.1. 
 
ii.    Preparation of Pseudomonas aeruginosa colony 
Pseudomonas aeruginosa will be prepared as per in 5.7.1.2. 
 
iii.    Preparation of topical tualang honey 
Topical tualang honey will be prepared as per in 5.7.1.3. 
 
iv.   Induction of Pseudomonas aeruginosa keratitis 
Pseudomonas aeruginosa will be induced as mentioned in 5.7.1.4. 
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v.   Treatment regime 
24 hours after the injection, the rabbits will be randomized into the 
following groups; 
 
i) Group A – gutt gentamicin 0.3%. 
ii) Group B – gutt tualang honey 30%. 
iii) Group C – gutt gentamicin 0.3% and gutt tualang honey 30%. 
 
The eye drops will be administered every 2 hours for first 24 hours 
in all 3 groups. Subsequently, the medications will be administered 
every 4 hours until day 7 post induction of Pseudomonas 
aeruginosa. 
 
vi.    Clinical eye examination 
Clinical features will be evaluated at day 1, 2, 3, 5, and 7 as per 
mentioned in 5.7.1.5. 
 
vii.    Preparation of the corneal button 
The cornea will be excised as per mentioned in 5.7.1.6. 
 
viii.    Calculation of CFU count 
The procedure will be performed as described in 5.7.1.7. 
 
 
